Bruce Cranna First-class analyst Country: USA

1. Renowned Analyst
2. Career at Leerink Swann & Co.
3. Wall Street Accolades
4. Prior Experience
5. Education

Renowned Analyst

Bruce Cranne is an exceptional analyst with unparalleled expertise in the healthcare and diagnostics industries. His astute financial forecasts for organizations like Becton Dickinson & Co. and Beckman Coulter have earned him recognition as one of Wall Street's top analysts.

Career at Leerink Swann & Co.

Since 2002, Cranne has been an integral member of Leerink Swann & Co., a leading healthcare investment firm. Leerink Swann & Co. has been recognized as Best Firm in Biotechnology, Medical Supplies and Devices, and Pharmaceuticals by Forbes. The firm provides a comprehensive suite of services, including biomedical services, consultation, and more.

Wall Street Accolades

Cranne's exceptional analytical skills have been recognized by the industry. In 2008, The Wall Street Journal named him among the most influential Wall Street analysts. He has also been ranked among the world's Best Analysts.

Prior Experience

Prior to Leerink Swann & Co., Cranne served as director and senior analyst at Equity Capital Markets and was recognized as a Top Analyst. He also held positions as vice president of the Equity Capital Group at Chicago Corporation, senior consultant at Coopers & Lybrand, and senior analyst at Blue Cross and Blue Shield of Massachusetts.

Education

Cranne holds a Bachelor of Science degree in Economics from the University of Massachusetts and an MBA from Northeastern University.